Human BioMolecular Atlas Program (HuBMAP) Other Transaction Awards Frequently Asked Questions (FAQs)
We appreciate your interest in the Human BioMolecular Atlas Program (HuBMAP) and hope that you and your team will choose to submit an application. In order to maximize your chances of success, we would like to provide some guidance that may be helpful. For additional clarification of these or other issues, we encourage you to send an email to HuBMAP@mail.nih.gov or talk with the scientific contacts listed in the RFA to which you are applying.
General Questions
1. What is an Other Transaction (OT) award?
2. What is the difference between an OT award, a grant, cooperative agreement, and a contract?
3. What is an “OT2” mechanism?
4. What is the difference between OT1, OT2, and OT3?
5. Who is eligible to apply for an Other Transaction Award?
6. Is partnering permitted among eligible applicants?
General Questions General Questions
Application
7. Does the NIH have a forum for large and small organizations to discover one another?
8. Where are Other Transaction (OT) Funding Opportunity Announcements (FOAs) posted?
11. Is a System for Award Management (SAM) registration required?
12. Is eRA Commons registration required?
13. Do I need a signing official to submit an OT application?
14. When is the “OT2” application due?
15. Will there be a required Letter of Intent (LOI) for OT applications?
16. What is the “Invitation to Submit”?
17. Can HuBMAP select only certain portions described in an LOI?
18. Can I be involved in more than one team/can I submit more than one LOI?
19. How long will it take to hear about my letter of intent (LOI)?
20. Will I get feedback on my LOI submission?
21. What is the most common problem you see in OT LOIs?
22. Can I apply to both the OT award and grant announcements?
23. Are application due dates firm or is there a possibility that these dates may be extended?
Application Application
Review
25. What is “objective review”?
27. Will reviewer critiques be provided post-review?
28. Will impact scores be released post-review?
29. Will reviewer rosters be released post-review?
30. May I appeal the results of the LOI review or objective review?
31. What are the review criteria for “OT2” applications?
32. I’m concerned about how the reviewers will interpret X.
33. How much emphasis is placed on innovation?
34. Can I ask you about my specific aims and hypothesis?
Review Review
Award Management
36. If selected, when can I expect to receive funding?
39. What is the initial period of performance?
40. What are the Terms & Conditions (T&C) of the Other Transaction (OT) award?
41. How long is the project period under an Other Transaction (OT) award?
42. Will a Project Officer be assigned to oversee my Other Transaction (OT) award?
Award Management Award Management
Post-Award Management
43. What is the role of the HuBMAP Program Manager (PM)?
44. What is the role of the HuBMAP Agreement Officer (AO)?
45. What are post-award changes?
46. How are post-award changes decided and approved?
47. May post-award changes be appealed or disputed?
48. Does receiving an OT award affect my Early Stage Investigator or New Investigator status?
Post-Award Management Post-Award Management
FOA Specific Questions
49. HIVE: What are the expectation for data archiving?
50. HIVE: What Consortium-building and community-engagement activities are encouraged?
51. HIVE: For the Tools Component, is the focus on new tool development or integration of tools?
53. HIVE: What is the scope of the data to be archived in the HIVE?
54. HIVE: Who is eligible to apply?
55. HIVE: How many awards will be made?
FOA Specific Questions FOA Specific Questions
ABBREVIATIONS
AO Agreement Officer
D&B Dun and Bradstreet
DUNS Data Universal Numbering System
HIVE HuBMAP Integration, Visualization, and Engagement
LOI Letter of Intent
NoA Notice of Award
OT Other Transaction
PM Program Manager
ROA Research Opportunity Announcement
SAM System for Award Management
T&C Terms & Conditions
ABBREVIATIONS ABBREVIATIONSThis page last reviewed on January 5, 2021